COVID-19: Wockhardt in discussions with vaccine developers to offer drug substance

According to the company, the UK government has reserved one fill and finish production line at Wockhardt UK for its exclusive use for 18 months in order to guarantee the supply of vaccines required to fight against COVID-19.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3lkAtPK
via IFTTT